Matthew Carpenter PhD

Biography

Dr. Carpenter received his Ph.D. in Clinical Psychology from the University of Vermont in 2003, and relocated to the Medical University of South Carolina (MUSC) in Charleston SC, where he currently is a Tenured Professor, serving as co-leader of the Cancer Control Program within MUSC Hollings Cancer Center. His primary research interests relate to tobacco use across a broad methodological continuum: from lab-based studies of craving and nicotine dependence, to small and large scale clinical trials for smoking cessation, to public health policy for effective tobacco control. He has led a number of large national cessation trials, including a large cluster randomized trial in primary care.  He leads a robust program of research on alternative products, including clinical trials of e-cigarettes. He is an innovator of methods for remote clinical trials. Dr. Carpenter has had continuous funding from NIH since 2007. Prior/current funding includes a Career Development Award (K23), multiple R01s and R21s (NCI & NIDA), and foundation grants, all as Principal Investigator. Throughout, Dr. Carpenter is keen on trainee development, encouraging a long line of trainees to develop their own science (primary mentor for T32, F32, K07, K01, 2 K23s, 3 ACS and various NIH LRP recipients) and progress in their own professional careers (>6 prior trainees now in academia). He has served on a number of NIH study sections, including several as Chair. Most recently (2022- ), Dr. Carpenter has taken on a new role within NIH CSR Advisory Council (CSRAC). A full listing of Dr. Carpenter’s publication history can be found in PubMed link above.